Wnt-14b inhibitors are a class of chemical compounds that specifically target and modulate the Wnt signaling pathway, particularly through the inhibition of Wnt-14b, a protein involved in this pathway. The Wnt signaling pathway plays a crucial role in various cellular processes, including cell proliferation, differentiation, and migration, making it a fundamental component of developmental biology. Wnt-14b, a member of the Wnt family of glycoproteins, is known to activate particular downstream signaling cascades that regulate gene expression, influencing cellular behavior. By inhibiting Wnt-14b, these compounds interfere with the signal transduction processes associated with this protein, leading to downstream effects on cellular function and molecular pathways.
The molecular mechanisms through which Wnt-14b inhibitors exert their effects often involve the binding to specific domains of the Wnt-14b protein or its interacting partners, preventing the activation of key receptors such as Frizzled and LRP5/6. This disruption can halt the accumulation of β-catenin, a central player in the canonical Wnt pathway, thereby blocking the activation of Wnt target genes. In addition to influencing β-catenin-mediated processes, Wnt-14b inhibitors may also impact non-canonical Wnt signaling pathways, affecting cytoskeletal dynamics and cellular polarity. The specificity of these inhibitors for Wnt-14b ensures that they selectively modulate particular aspects of Wnt signaling, without broadly affecting other Wnt family members, which is crucial for their precise control of cellular pathways. The development of these inhibitors provides valuable tools for researchers studying the fine-tuned regulatory mechanisms of Wnt signaling in various biological systems.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
Inhibits Wnt/β-catenin pathway by promoting β-catenin degradation, affecting Wnt-14b related signaling. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Prevents Wnt protein secretion, indirectly reducing Wnt-14b signaling by limiting its availability. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
Inhibitor of Wnt production and secretion, potentially decreasing Wnt-14b activity by reducing ligand availability. | ||||||
SP2509 | 1423715-09-6 | sc-492604 | 5 mg | $284.00 | ||
Promotes differentiation by inhibiting Wnt/β-catenin signaling, indirectly affecting Wnt-14b mediated processes. | ||||||
β-Catenin/Tcf Inhibitor, FH535 | 108409-83-2 | sc-221398 sc-221398A | 10 mg 50 mg | $182.00 $374.00 | 7 | |
Dual inhibitor of Wnt/β-catenin and PPAR signaling, which could indirectly impact Wnt-14b activity. | ||||||
PNU-74654 | 113906-27-7 | sc-258020 sc-258020A | 5 mg 25 mg | $131.00 $495.00 | 7 | |
Disrupts Wnt/β-catenin interaction, potentially affecting downstream signaling of Wnt-14b. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Specifically binds to CBP/β-catenin, disrupting Wnt/β-catenin signaling pathway, indirectly influencing Wnt-14b function. | ||||||
PRI-724 | 1422253-38-0 | sc-507535 | 25 mg | $260.00 | ||
Targets the CBP/β-catenin complex, indirectly modulating Wnt-14b activity through Wnt/β-catenin pathway inhibition. | ||||||
WIKI4 | 838818-26-1 | sc-397021 sc-397021A | 5 mg 25 mg | $90.00 $351.00 | ||
Inhibits the Wnt/β-catenin pathway, potentially impacting signaling pathways involving Wnt-14b. | ||||||